Portfolio choice in retirement: Health risk and the demand for annuities,housing, and risky assets

In a life-cycle model, a retiree faces stochastic health depreciation and chooses consumption, health expenditure, and the allocation of wealth between bonds, stocks, and housing. The model explains key facts about asset allocation and health expenditure across health status and age. The portfolio share in stocks is low overall and is positively related to health, especially for younger retirees. The portfolio share in housing is negatively related to health for younger retirees and falls significantly in age. Finally, out-of-pocket health expenditure as a share of income is negatively related to health and rises in age.     

县域医改该何去何从——关于深圳罗湖医改和茂名高州医改的调研启示

本文通过梳理深圳罗湖推进紧密型医联体建设和茂名高州深化县级公立医院综合改革的主要举措,提出在深化县域医改时要坚持三个方向,即坚持加强党的领导,坚持建设整合型医疗服务体系,坚持三医联动.     

Business Models for Frugal Innovation in Emerging Markets: The Case of the Medical Device and Laboratory Equipment Industry

This study investigates business models for frugal innovation (i.e. a specific form of resource-constrained innovation) in the medical device and laboratory equipment industry in the context of emerging markets. Based on original data from five case studies, we investigate how firms can set up value creation and value capturing mechanisms to reach new customer segments in remote rural areas with unprecedented value propositions. With this research, we contribute to the literature on frugal innovation and business models in emerging markets. It is among the first empirical studies to apply a fine-grained perspective on resource-constrained innovation in emerging markets. In doing so, we focus on its most disruptive form, which is when these innovations entail entirely new applications. We advance and detail the value proposition for frugal innovation in these industries and argue that frugal innovation create new markets. Further, we show how firms set up their value creation and value capturing mechanisms to achieve the value proposition and identify two distinct Research & Development (R&D) strategies for frugal innovation.     

Modelling the cost of providing ambulance services

The aim of this paper is to study how regional demography and accessibility patterns influence the cost of providing ambulance services. A secondary aim is to project future costs and demand for ambulance services based on population projections. We use data from south-east Norway, an area with both urban and rural areas. Our results show that accessibility patterns, urbanisation and demography are important factors in determining costs. Furthermore, an ageing population and an ongoing process of urbanisation will have an impact on both the demand for ambulance transport and the cost of providing these services.     

新型农村合作医疗缓解因病致贫效果指数构建

本文将衡量金融风险的思想引入新型农村合作医疗的政策实践中,将农民的因病致贫看作一种风险加以防范,提出一种直观、可靠、易于操作的单一评价指标——新农合缓解因病致贫效果指数,并利用广东省五个地区微观调研数据,对这一评价指标进行了实证检验。因为满足因果关联性、预测性和普遍适用性要求,这一指数有利于对新型农村合作医疗实施效果在不同地区的横向比较,并对决策者调整政策参数以实现预定的政策目标具有重要意义。     

浅析病案信息在保险理赔中的利用

病案资料在保险理赔中具有重要的作用,分析病案信息资料在保险理赔利用过程中存在的问题,探讨通过提高保险理赔人员的医学素质、职业责任感、促进医疗机构与保险机构合作,可以加强病案信息的利用,提升保险理赔水平。     

医学类独立学院教学管理模式探讨

医学类独立学院是指按照新的机制和模式举办的医学类本科层次二级学院。作为公办普通本科医学院校补充,已经得到了迅速发展。本文从提高办学质量和办学水平的目的出发,就独立学院教学管理模式进行探讨。     

新型农村合作医疗保险满意度分析——基于兴宁市农户调查的Logistic回归模型

新农合作为中国政府近期的一项重大的民生举措,对改善亿万农村居民的医疗保障和生活水平的提高具有深远的意义和影响,而了解农民对新型农村医疗保险制度的满意程度和存在的要求无疑是确保新农合制度能够长期持续运行的关键所在。本文基于对兴宁市问卷调查数据建立有序logistic回归模型进行满意度的实证分析。结果表明个人缴费金额、报销手续和定点医院条件是影响农民对新农合满意度的三个最主要因素。本文的政策启示是:在维持个人缴费金额的前提下,通过改善医疗条件、提高服务质量可以大幅度地提高参合农民的满意度,并达到政府、医疗单位和农民三赢的局面,从而使得新农合能够持续稳定地有效运行。     

Economic impact of severe and non-severe hypoglycemia in patients with Type 1 and Type 2 diabetes in the United States

Abstract

Objective:

To identify the direct and indirect costs of hypoglycemia in patients with Type 1 or Type 2 diabetes mellitus (DM) in the US setting.     

Estimated medical cost reductions for paliperidone palmitate vs placebo in a randomized,double-blind relapse-prevention trial of patients with schizoaffective disorder

Abstract

Objective:

The objective of this economic model was to estimate the difference in medical costs among patients treated with paliperidone palmitate once-monthly injectable antipsychotic (PP1M) vs placebo, based on clinical event rates reported in the 15-month randomized, double-blind, placebo-controlled, parallel-group study of paliperidone palmitate evaluating time to relapse in subjects with schizoaffective disorder.